These lab-built choices were not created with recreational use in mind. In the 1990s, John W. Huffman and also a crew of fellow chemists at Clemson University established many of the initial formulas for synthetic cannabinoid receptor agonists (SCRAs), a household of substances that imitate the physiological and psychological impacts of cannabis on